For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Dose-Finding Level 2 RT | Dose-Finding Level 2 RT: Adult: Pazopanib 800 mg; Pediatric: Pazopanib 450 mg/m2 | 3 | None | 2 | 10 | 5 | 10 | View |
| Regimen A | Regimen A: Chemoradiation plus pazopanib | 5 | None | 33 | 46 | 20 | 46 | View |
| Regimen B | Regimen B: Chemoradiation alone | 9 | None | 8 | 43 | 10 | 43 | View |
| Regimen C | Regimen C: Radiation therapy plus pazopanib | 0 | None | 1 | 6 | 1 | 6 | View |
| Regimen D | Regimen D: Radiation therapy alone | 2 | None | 0 | 6 | 0 | 6 | View |
| Dose-Finding Level 1 CR | Dose-Finding Level 1 CR: Adult: Pazopanib 600 mg; Pediatric: Pazopanib 350 mg/m2 | 1 | None | 6 | 9 | 4 | 9 | View |
| Dose-Finding Level 1 RT | Dose-Finding Level 1 RT: Adult: Pazopanib 600 mg; Pediatric: Pazopanib 350 mg/m2 | 4 | None | 6 | 9 | 2 | 9 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Thromboembolic event | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv5 | View |
| Pulmonary edema | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Anorexia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Creatinine increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Febrile neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv5 | View |
| Fever | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Hallucinations | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv5 | View |
| Hyperkalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypoxia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Ileus | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Mucositis oral | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Pain | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Pain in extremity | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv5 | View |
| Perforation bile duct | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | CTCv5 | View |
| Sepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Skin infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Wound dehiscence | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Wound infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Wound complication | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Acute kidney injury | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Alanine aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv5 | View |
| Atrial fibrillation | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv5 | View |
| Atrial flutter | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv5 | View |
| Blood and lymphatic system disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv5 | View |
| Blood bilirubin increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Blurred vision | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv5 | View |
| Chills | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Cognitive disturbance | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Death NOS | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Delirium | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv5 | View |
| Depression | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv5 | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Electrocardiogram QT corrected interval prolonged | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Encephalopathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Esophagitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Febrile neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv5 | View |
| Fever | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Gait disturbance | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| General disorders and administration site conditions - Other, specify | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Hyperglycemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypokalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hyponatremia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypophosphatemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypoxia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Laryngospasm | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Lymphocyte count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Mucositis oral | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Multi-organ failure | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Neutrophil count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Pain in extremity | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv5 | View |
| Photophobia | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv5 | View |
| Platelet count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Pleural effusion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Pneumothorax | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Renal and urinary disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Sepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Sinus tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv5 | View |
| Skin hypopigmentation | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv5 | View |
| Skin infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Stroke | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Syncope | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Thromboembolic event | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv5 | View |
| Upper respiratory infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Urinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Uterine hemorrhage | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | CTCv5 | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Wound dehiscence | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Wound infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| White blood cell decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Ejection fraction decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Wound complication | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Postoperative hemorrhage | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Dermatitis radiation | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Lung infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Soft tissue infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Non-cardiac chest pain | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Device related infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Alanine aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Cardiac disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv5 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv5 | View |
| Lymphocyte count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Neutrophil count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Platelet count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Radiation recall reaction (dermatologic) | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Wound dehiscence | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| White blood cell decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Wound complication | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Localized edema | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Alanine aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv5 | View |
| Aspartate aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Febrile neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv5 | View |
| Hyperkalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Wound complication | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Palmar-plantar erythrodysesthesia syndrome | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv5 | View |
| Lipase increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Lymphocyte count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Neutrophil count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Platelet count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Urinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Wound dehiscence | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Wound infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| White blood cell decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Hyperphosphatemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv5 | View |
| Hypokalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv5 | View |
| Infections and infestations - Other, specify | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |